Immunotherapy-related adverse effects: how to identify and treat them in the emergency departmentAugust 26, 2018ImmunotherapyPatient & Survivor Care
Extramedullary plasmacytoma of the thyroid, refractory to radiation therapy and treated with bortezomibAugust 26, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
Salivary ductal adenocarcinoma with complete response to androgen blockadeAugust 26, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
Characteristics of urgent palliative cancer care consultations encountered by radiation oncologistsAugust 26, 2018Patient & Survivor Care
More biosimilars reach the market in efforts to improve access and cut costsAugust 26, 2018Patient & Survivor Care
An unusual case of primary cardiac prosthetic valve-associated lymphomaAugust 15, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Durable response to pralatrexate for aggressive PTCL subtypesAugust 15, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
New myeloma drugs improve response and extend survivalAugust 15, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
CAR T-cell approvals: multiple myeloma likely next upJune 21, 2018Lymphoma & Plasma Cell DisordersPatient & Survivor Care
Tumor heterogeneity: a central foe in the war on cancerJune 21, 2018ImmunotherapyPatient & Survivor Care
Recurrence of a small gastric gastrointestinal stromal tumor with high mitotic indexJune 21, 2018GastroenterologyPatient & Survivor Care
Effective management of severe radiation dermatitis after head and neck radiotherapyJune 21, 2018Head & Neck/Thyroid CancersPatient & Survivor Care
